Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecilia Roux

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The dark side of immunotherapy: pancreatic cancerGianluca Mucciolo, Cecilia Roux, Alessandro Scagliotti, et al.
Cancers|February 22, 2018
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo PartnersPaola Cappello, Claudia Curcio, Giorgia Mandili, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
IL17A Depletion Affects the Metabolism of Macrophages Treated with GemcitabineCecilia Roux, Gianluca Mucciolo, Joanna Kopecka, et al.
Oncotarget|January 7, 2016
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrestMichela Capello, Sammy Ferri-Borgogno, Chiara Riganti, et al.
Oncotarget|December 10, 2017
Endogenous glutamine decrease is associated with pancreatic cancer progressionCecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 2, 2024
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancerClaudia Curcio, Gianluca Mucciolo, Cecilia Roux, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functionsGianluca Mucciolo, Claudia Curcio, Cecilia Roux, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2019
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1Cecilia Roux, Soode Moghadas Jafari, Rahul Shinde, et al.
Clinical and Translational Medicine|August 20, 2025
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinomaGiorgia Tiberi, Alessandro Scagliotti, Claudia Curcio, et al.
Iscience|July 5, 2020
Immune Cell Associations with Cancer RiskLuis Palomero, Ivan Galván-Femenía, Rafael de Cid, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
The dark side of immunotherapy: pancreatic cancerGianluca Mucciolo, Cecilia Roux, Alessandro Scagliotti, et al.
Cancers|February 22, 2018
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo PartnersPaola Cappello, Claudia Curcio, Giorgia Mandili, et al.
Antioxidants (Basel, Switzerland)|April 3, 2021
IL17A Depletion Affects the Metabolism of Macrophages Treated with GemcitabineCecilia Roux, Gianluca Mucciolo, Joanna Kopecka, et al.
Oncotarget|January 7, 2016
Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrestMichela Capello, Sammy Ferri-Borgogno, Chiara Riganti, et al.
Oncotarget|December 10, 2017
Endogenous glutamine decrease is associated with pancreatic cancer progressionCecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 2, 2024
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancerClaudia Curcio, Gianluca Mucciolo, Cecilia Roux, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functionsGianluca Mucciolo, Claudia Curcio, Cecilia Roux, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 17, 2019
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1Cecilia Roux, Soode Moghadas Jafari, Rahul Shinde, et al.
Clinical and Translational Medicine|August 20, 2025
The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinomaGiorgia Tiberi, Alessandro Scagliotti, Claudia Curcio, et al.
Iscience|July 5, 2020
Immune Cell Associations with Cancer RiskLuis Palomero, Ivan Galván-Femenía, Rafael de Cid, et al.
Pageof 2